Waystar (NASDAQ:WAY) versus OptimizeRx (NASDAQ:OPRX) Head to Head Survey

OptimizeRx (NASDAQ:OPRX) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are held by institutional investors. 7.5% of OptimizeRx shares are held by insiders. Comparatively, 3.5% of Waystar shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares OptimizeRx and Waystar”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	1.30	$5.13 million	$0.23	32.87
Waystar	$1.10 billion	4.48	$112.09 million	$0.70	36.73

Waystar has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OptimizeRx and Waystar, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Waystar	0	4	18	2	2.92

OptimizeRx currently has a consensus price target of $11.43, suggesting a potential upside of 51.17%. Waystar has a consensus price target of $34.67, suggesting a potential upside of 34.84%. Given OptimizeRx’s higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than Waystar.

Profitability

This table compares OptimizeRx and Waystar’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Waystar	11.18%	7.03%	4.75%

Volatility & Risk

OptimizeRx has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, Waystar has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500.

Summary

Waystar beats OptimizeRx on 9 of the 15 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.